CDI Breakthroughs Lead to New Drug Development Deal for Deadly NTM Bacteria

Hackensack Meridian Center for Discovery and Innovation (CDI)’s top non-tuberculous mycobacteria scientists, Drs. Véronique Dartois and Thomas Dick have developed new compounds which are now subject of a new collaboration and license agreement with BioVersys AG.